FDA AMENDED_483 - KRS Global Biotechnology, Inc - August 06, 2019

FDA AMENDED_483 for KRS Global Biotechnology, Inc on August 06, 2019. Product: Devices. Access full analysis and detailed observations.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA AMENDED_483 for KRS Global Biotechnology, Inc on August 06, 2019. Product: Devices. Access full analysis and detailed observations.

Violation Codes

21 CFR 211.160

21 CFR 211.113

21 CFR 211.100

21 CFR 211.192

21 CFR 211.194

21 CFR 211.166

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

KRS Global Biotechnology, Inc

Inspection Date

August 6, 2019

Product Type

Devices

Office

Center for Devices and Radiological Health

People

ID: 2aa78260-6652-436d-ae7f-f1eb342c0ea2

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox